M&A / Deals Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion Big Molecule WatchOn April 22, 2026 Amneal Pharmaceuticals, Inc.Read full story pharminent May 4, 2026 (Last updated: May 5, 2026) Big Molecule Watch On April 22, 2026 Amneal Pharmaceuticals, Inc. Read full story Post navigation Previous: UCB Enters $2.2 Billion Deal to Acquire Candid TherapeuticsNext: Cytospire hauls in $83M for a new type of T cell engager Related Stories M&A / Deals UCB doubles down on TCEs with $2.2bn Candid buyout pharminent May 5, 2026 M&A / Deals Latus Bio secures $97m in funding to boost gene therapy access pharminent May 5, 2026 M&A / Deals Autoimmune disease biotech Odyssey sets terms for $225m IPO pharminent May 5, 2026
